When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
On 60 Minutes, Dr. Jon LaPook explores how AI is revolutionizing mental health care by filling the gap caused by a critical shortage of human therapists. He highlights…
James Januzzi, MD, explores the use of cardiac biomarkers like natriuretic peptides and troponin in heart failure management. He discusses their evolution from diagnostic tools to predictors of…
Ellis Parker, MSN, RN, from Level Up RN, discusses the different levels of health prevention—primary, secondary, and tertiary—and the significant role of health determinants. She uses the community…
This video provides a comprehensive overview of pediatric asthma, focusing on how to approach a wheezing child. It differentiates between stridor and wheezing, explaining their causes and characteristics…
In this detailed webinar on systemic mastocytosis, Dr. Miti introduces Professor Prithviraj Bose, an expert in the field, who discusses the complexities of diagnosing and managing systemic mastocytosis…
In this medical training video, Elena Zanchini, MD, guides viewers through a comprehensive review of gastrointestinal and hepatological issues, focusing on diagnosing conditions such as infectious diarrhea and…
Alina Bridges, MD, a dermatologist and dermatopathologist at Mayo Clinic, explains psoriasis, a common chronic inflammatory disease affecting the skin, nails, and joints. In this video, she outlines…
Christopher Patriquin, MD, Hematologist at Toronto General Hospital, discusses the challenges of diagnosing paroxysmal nocturnal hemoglobinuria (PNH) due to its varied symptoms, such as thrombosis, anemia, and unusual…
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease where red blood cells rupture due to the immune system mistakenly attacking them. This happens because of a mutation…
Antonio Risitano, MD, PhD, highlights exciting developments in treatments for paroxysmal nocturnal hemoglobinuria (PNH), specifically the introduction of complement inhibitors that have transformed the prognosis of the disease.…
